Omega-3 Fatty Acid Supplements for Chronic Epilepsy
J Gordon Millichap;
- Publisher: Pediatric Neurology Briefs Publishers
- Journal: Pediatric Neurology Briefs (issn: 1043-3155, eissn: 2166-6482)
- Subject: Experimental Studies | Antiepileptic Drug | RJ1-570 | Pediatrics | Fatty Acidmesheuropmc: lipids (amino acids, peptides, and proteins)
Omega-3 fatty acid (FA) supplements (lg EPA and 0.7g DHA daily) were used in the treatment of 58 patients with refractory epilepsy, in a 12-week double-blind, placebo-controlled trial conducted by researchers at the UCL Institute of Neurology, London, UK.
- Metrics No metrics available